Jinling Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Jinling Pharmaceutical Co Ltd cash flow reinvestment rate. Jinling Pharmaceutical Co Ltd (000919) has a Cash Flow Reinvestment Rate of 0.17x as of September 2025, reinvesting CN¥12.56 Million (capex CN¥12.56 Million ) from operating cash flow of CN¥74.01 Million. Explore 000919 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jinling Pharmaceutical Co Ltd (1999–2024)
Cash flow reinvestment rate of Jinling Pharmaceutical Co Ltd from 1999 to 2024. Historical reinvestment intensity for Jinling Pharmaceutical Co Ltd across 26 annual periods. Explore reinvestment intensity of Jinling Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Jinling Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (1999–2024)
Jinling Pharmaceutical Co Ltd cash flow reinvestment rate by year from 1999 to 2024. Year-by-year capital reinvestment analysis for Jinling Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Jinling Pharmaceutical Co Ltd generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.80x | CN¥739.80 Million | CN¥154.19 Million | CN¥201.63 Million | ▲ +80.7% |
| 2023 | 2.65x | CN¥421.94 Million | CN¥158.92 Million | CN¥186.25 Million | ▲ +30.4% |
| 2022 | 2.04x | CN¥530.76 Million | CN¥260.59 Million | CN¥309.64 Million | ▲ +264.2% |
| 2021 | 0.56x | CN¥163.32 Million | CN¥292.03 Million | CN¥162.76 Million | ▼ -57.7% |
| 2020 | 1.32x | CN¥412.12 Million | CN¥311.46 Million | CN¥291.41 Million | ▲ +104.1% |
| 2019 | 0.65x | CN¥302.01 Million | CN¥465.85 Million | CN¥125.71 Million | ▲ +4.0% |
| 2018 | 0.62x | CN¥270.52 Million | CN¥433.83 Million | CN¥136.42 Million | ▲ +259.1% |
| 2017 | 0.17x | CN¥76.94 Million | CN¥443.11 Million | CN¥66.80 Million | ▼ -87.0% |
| 2016 | 1.34x | CN¥128.57 Million | CN¥96.15 Million | CN¥107.45 Million | ▲ +56.2% |
| 2015 | 0.86x | CN¥181.83 Million | CN¥212.45 Million | CN¥104.31 Million | ▲ +181.6% |
| 2014 | 0.30x | CN¥91.14 Million | CN¥299.89 Million | CN¥91.14 Million | ▼ -42.8% |
| 2013 | 0.53x | CN¥144.05 Million | CN¥271.21 Million | CN¥144.05 Million | ▼ -34.7% |
| 2012 | 0.81x | CN¥188.76 Million | CN¥232.12 Million | CN¥188.76 Million | ▲ +71.0% |
| 2011 | 0.48x | CN¥82.20 Million | CN¥172.82 Million | CN¥82.20 Million | ▼ -11.4% |
| 2010 | 0.54x | CN¥95.48 Million | CN¥177.81 Million | CN¥95.48 Million | ▲ +4.7% |
| 2009 | 0.51x | CN¥96.60 Million | CN¥188.41 Million | CN¥96.60 Million | ▲ +607.8% |
| 2008 | 0.07x | CN¥22.11 Million | CN¥305.26 Million | CN¥22.11 Million | ▼ -59.2% |
| 2007 | 0.18x | CN¥20.97 Million | CN¥118.06 Million | CN¥20.97 Million | ▲ +6.5% |
| 2006 | 0.17x | CN¥23.09 Million | CN¥138.50 Million | CN¥23.09 Million | ▼ -50.2% |
| 2005 | 0.33x | CN¥36.61 Million | CN¥109.29 Million | CN¥36.61 Million | ▼ -26.1% |
| 2004 | 0.45x | CN¥72.47 Million | CN¥159.81 Million | CN¥72.47 Million | ▲ +29.4% |
| 2003 | 0.35x | CN¥56.73 Million | CN¥161.86 Million | CN¥56.73 Million | ▼ -55.5% |
| 2002 | 0.79x | CN¥102.63 Million | CN¥130.36 Million | CN¥102.63 Million | ▼ -54.6% |
| 2001 | 1.73x | CN¥160.27 Million | CN¥92.49 Million | CN¥160.27 Million | ▲ +198.0% |
| 2000 | 0.58x | CN¥134.49 Million | CN¥231.31 Million | CN¥134.49 Million | ▼ -67.7% |
| 1999 | 1.80x | CN¥71.57 Million | CN¥39.77 Million | CN¥71.57 Million | — |